Evaluation of portable point-of-care CD4 counter with high sensitivity for detecting patients eligible for antiretroviral therapy.
BACKGROUND: Accurate, inexpensive point-of-care CD4+ T cell testing technologies are needed that can deliver CD4+ T cell results at lower level health centers or community outreach voluntary counseling and testing. We sought to evaluate a point-of-care CD4+ T cell counter, the Pima CD4 Test System,...
Main Authors: | Yukari C Manabe, Yaping Wang, Ali Elbireer, Brandon Auerbach, Barbara Castelnuovo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3334961?pdf=render |
Similar Items
-
CD4 enumeration technologies: a systematic review of test performance for determining eligibility for antiretroviral therapy.
by: Rosanna W Peeling, et al.
Published: (2015-01-01) -
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women
by: Sturt Amy S, et al. -
Commentary on: Serum Albumin for Tuberculosis in HIV Infected Patients Eligible for Antiretroviral Therapy
by: Viroj Wiwanitkit
Published: (2013-12-01) -
Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda
by: Sempa Joseph, et al.
Published: (2012-09-01) -
Computed CD4 percentage as a low-cost method for determining pediatric antiretroviral treatment eligibility
by: Colebunders Robert, et al.
Published: (2008-03-01)